Fluidigm Announces $60 Million Public Offering of Common Stock

News   Aug 22, 2012

 
Fluidigm Announces $60 Million Public Offering of Common Stock
 
 
 
 

RELATED NEWS

Pulmonary Thrombosis-on-a-Chip Developed

News

Model of blood clot formation in the lung allows for unprecedented study of human blood responses to organ-level injury and inflammation in vitro.

READ MORE

Microfluidics Industry: What will Trigger the Next Growth Spurt?

News

Diagnostics, point-of-care and pharmaceutical research will drive the rapidly-expanding microfluidic products industry to a potential value of US$23 billion by 2022.

READ MORE

Graphene-Based Sensor Could Improve Evaluation, Diagnosis and Treatment of Asthma

News

The new graphene-based sensor could help detect inflammation in the lungs and lead to personalized asthma management.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Microfluidics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE